|
|
3:00-3:05 pm
|
Welcoming
Frederick Hayden |
3:05-3:50 pm
|
Keynote Speaker:
Pathogenesis of Zoonotic Respiratory Viral Infections: Studies in
SARS and Avian Influenza
Malik Peiris, University of Hong Kong
|
Session I: Epidemiology/Impact
|
|
|
| Chair: |
Robert Webster, St. Jude Children's Research
Hospital and Director,
World Health Organization Collaborating Center for
Studies on the
Ecology of Influenza, Memphis, Tennessee |
3:50-4:20 pm
|
The New Respiratory Viruses - Update on Boca
Maria Soderlund, Venermo, Haartman Institute, University of Helsinki, Finland |
4:20-5:00 pm
|
Update on Corona NL63 and HKU1
Lia van der Hoek, University of
Amsterdam, The Netherlands
and
Patrick Woo, University of Hong Kong, Pokfulam, Hong Kong
SAR, China |
5:00-5:30 pm
|
Evolution and Prevalence of Avian Influenza Viruses in Southern China
Yi Guan, The University of Hong Kong, Pokfulam, Hong Kong SAR, China |
5:30-6:00 pm
|
COFFEE BREAK
Sponsored by The Macrae Group |
6:00-6:15 pm
|
Epidemiology of Respiratory Viruses: a Hospitalbased
Cohort Study
Laurent Kaiser, University Hospitals of Geneva,
Switzerland |
6:15-6:30 pm
|
Viral Community-Acquired Pneumonia in Adults: the
Role of PCR
Lance C. Jennings, Canterbury Health Laboratories,
Christchurch, New Zealand) |
6:30-7:00 pm
|
Poster Review
Albert Osterhaus, Erasmus MC, Rotterdam, The Netherlands |
7:00-9:00 pm
|
Welcoming Reception
Sponsored by F. Hoffman-La Roche Ltd. |
| 7:00-8:00 am |
CONTINENTAL BREAKFASK
|
Session II: Minisymposium on Pandemic Influenza
|
|
Chair: Malik Peiris, University of Hong Kong
|
8:00-8:30 am
|
Current Animal H5 Situation
Robert Webster, St. Jude Children's
Research Hospital and Director, World Health Organization
Collaborating Center for Studies on the Ecology of Influenza, Memphis,
Tennessee |
8:30-9:00 am
|
Use of Vaccination in Asia for H5N1 HAI in Poultry
Les Sims, Asia Pacific Veterinary Information Services. Queensland, Australia |
9:00-9:30 am
|
Novel Approaches to Human H5 Vaccine Development
Nancy Cox, Atlanta, Georgia, CDC |
9:30-9:45 am
|
Comparison of the Effectiveness of Oseltamivir and
Zanamivir against Influenca A Infection in Children
Norio Sugaya,
Keiyu Hospital, Yokohama, Kanagawa, Japan |
9:45-10:00 am
|
Reduced Pathogenicity and Transmissibility of an
Oseltamivir Resistant Influenca Virus A (H3N2)Isolate (N294S)
John
Oxford, Retroscreen Virology Ltd., London, United Kingdom |
| 10:00-10:45 am |
Pandemic Panel Q&A |
| 10:45-11:15 am |
COFFEE BREAK
Sponsored by The Macrae Group
|
Session III: Virology and Diagnostics
|
|
Chair: Menno de Jong, Oxford University Clinical
Research Unit,
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
|
11:15-12:00 pm
|
Non-Pathogen Specific Diagnostics
David Relman, Stanford University, California, USA |
12:00-12:15 pm
|
New Unrecognized Human Rhinoviruses are
Common Causes of Respiratory Illnesses in Infants
Wai-Ming Lee,
University of Wisconsin, Madison, Wisconsin, United States |
12:15-12:30 pm
|
Are We Using the Right Cells? Studies of Respiratory
Viruses with an In vitro Model of Well-differentiated Airway Epithelia
Liqun Zhang, University of North Carolina, Chapel Hill, North Carolina,
United States |
| 12:30-3:30 pm |
MID-DAY BREAK
|
3:30-4:00 pm
|
H5 Diagnostics- Advances Toward POC Detection
Menno de Jong, Hospital for Tropical Disease, Ho Chi Minh City,
Vietnam |
4:00-4:15 pm
|
The Antigenic and Genetic Evolution of Equine
Influenza Virus (H3N8) from 1963 to 2006
Nicola Lewis,
University of Cambridge, Kentford, United Kingdom
|
Session IV: Pathogenesis
|
|
Chair: Sebastian Johnston, National Heart & Lung Institute,
Imperial College, London, United Kingdom
|
4:15-5:00 pm
|
Innate Antiviral Immunity: Friend or Foe in the Lung?
Sebastian Johnston, National Heart & Lung Institute, Imperial College, London, UK |
5:00-5:30 pm
|
Pathophysiology of RSV in Infants
Robert Welliver, Women and Children™s Hospital, Buffalo, New York,
USA |
5:30-6:00 pm
|
Pre-Clinical Papers Literature Review
Malik Peiris, Univ of Hong Kong |
6:00-6:30 pm
|
COFFEE BREAK
Sponsored by The Macrae Group |
6:30-6:45 pm
|
Young Investigator Award Recipient:
Major Group Rhinovirus Induces Airway Inflammation and Anti-viral
Immune Responses in Transgenic Mice Expressing Human ICAM-1
Nathan W. Bartlett, National Heart and Lung Institute, Imperial College,
London, United Kingdom |
6:45-7:00 pm
|
The RNA Helicases RIG-1 and MDA-5 have a Central
Role in Anti-viral Responses to Rhinovirus
Michael R. Edwards,
National Heart and Lung Institute, Imperial College, London, United
Kingdom |
7:00-7:15 pm
|
Young Investigator Award Recipient:
Hypercytokinemia in Severe Human Influenza A Infections
Nelson
Lee, The Chinese University of Hong Kong, Sha Tin, N.T., Hong Kong
SAR, China |
7:15-7:45 pm
|
Rhinovirus Infections in Children: How Important Are They?
James Gern, University of Wisconsin, Madision, Wisconsin, USA |
7:45-9:00 pm
|
Poster Session
Wine & Cheese Reception
Sponsored by Novartis Vaccines |
| 7:30-8:30 am |
CONTINENTAL BREAKFAST
|
Session V: Clinical
|
|
Chair: John DeVincenzo, University of Tennessee,
Memphis, Tennessee, United States
|
8:30-9:00 am
|
Role of Enteroviruses in Respiratory Illness
Terho Heikkinen, Turku University Hospital, Turku, Finland |
9:00-9:30 am
|
Adenovirus Disease in Transplant
Mike Ison, Northwestern University,
Evanston, Illinois, USA |
9:30-9:45 am
|
Transmission of Rhinoviruses in Families with
Children
Ville Peltola, Turku University Hospital, Finland |
9:45-10:00 am
|
Heterologous Cell-mediated Immunity Priming Using
Adjuvanted H5N1 Candidate Vaccine
Martine J. Denis,
GlaxoSmithKline Biologicals, Rixensart, Belgium |
10:00-10:30 am
|
Literature Review: Clinical Papers
Terho Heikkinen, Turku University
Hospital, Turku, Finland |
10:30-11:00 am
|
COFFEE BREAK
Sponsored by GlaxoSmithKline
|
Session VI: Vaccinology and Prevention
|
|
Chair: Albert Osterhaus, Erasmus MC, Rotterdam,
The Netherlands
|
11:00-11:45 am
|
Adjuvant Strategies and Flu Vaccines
Albert Osterhaus, Erasmus MC,
Rotterdam, The Netherlands |
11:45-12:00 pm
|
Young Investigator Award Recipient:
Modified Virus-like Particles for the Delivery of a Conserved Influenza
Virus-Specific CTL Epitope
Wan-Shoo Cheong, Monash University,
Victoria, Australia |
12:00-12:15 pm
|
Safety and Immunogenicity of a Cell Culture (Vero)
Derived Whole Virus H5N1 Vaccine: A Phase I/II Dose Escalation Study
Noel Barrett, Baxter AG, Orth/Donau, Austria |
12:15-12:30 pm
|
Young Investigator Award Recipient:
Pandemic Influenza Preparedness: Cross-Reactive Immunity with an
Adjuvanted H5N1 Candidate Vaccine
Isabel Leroux- Roels, Ghent
University and Hospital, Ghent, Belgium |
| 12:30-3:30 pm |
MID-DAY BREAK |
| 3:30-4:15 pm |
Advances in Pandemic and Seasonal Influenza Vaccines
Klaus Stohr,
WHO, Geneva, Switzerland |
4:15-4:45 pm
|
Age Difference in Immune Responses: Pediatric Focus
Ruth Karron, Johns Hopkins University, Baltimore, Maryland, USA |
4:45-5:15 pm
|
Age Difference in Immune Response: Geriatric Focus
Janet McElhaney, University of Connecticut, Storrs, Connecticut |
5:15-5:45 pm
|
Numax Update
Jim Young, MedImmune Inc., Gaithersburg, Maryland, USA |
5:45-6:15 pm
|
COFFEE BREAK
Sponsored by The Macrae Group |
6:15-6:30 pm
|
Cluster Randomised Household Study of Mask Use
in Control of Respiratory Virus Transmission during the Australian
Winter of 2006
Raina MacIntyre, University of Sydney, Westmead,
New South Wales, Australia |
6:30-6:45 pm
|
Combination Adjuvants for the Induction of Potent,
Long-lasting Antibody and T cell Responses to Influenza Vaccines
Andreas Wack, Novartis Vaccines, Siena, Italy |
6:45-7:00 pm
|
Immunization with low dose Adjuvanted Split H5N1
Pandemic Vaccine Protects Ferrets Against Homologous and
Heterologous Challenges
Benoit Baras, GlaxoSmithKline Biologicals,
Rixensart, Belgium |
7:00-7:15 pm
|
Immunogenicity and protective Efficacy of a Novel
Polycationic Sphingolipid (CCS)-based Liposomal Intramuscular
Influenza Vaccine in the Ferret Experimental Model
Robert Lambkin-
Williams, Retroscreen Virology Ltd, London, United Kingdom |
8:00 pm
|
Special Lecture:
Vaccination, Diagnosis, Treatment and Prophylaxis of Seasonal Influenza
Nancy Cox, CDC, Atlanta, Georgia, USA |
8:30 pm
|
DINNER
Sponsored by Gilead Sciences |
7:30-8:30 am
|
CONTINENTAL BREAKFAST
|
Session VI: Vaccinology and Prevention (continued)
|
8:30-9:00 am
|
Passive Immunal Therapy for H5 Disease
Menno de Jong, Centre for
Tropical Disease, Ho Chi Minh City, Vietnam
|
Session VII: Antivirals and Therapeutics
|
|
Chair: Frederick Hayden, GIP/EPR/CDS,
World Health Organization, Geneva, Switzerland
|
9:00-9:45 am
|
Novel Anti-influenza Agents
Frederick Hayden, GIP/EPR/CDS,
World Health Organization, Geneva, Switzerland |
9:45-10:15 am
|
Effects of Leukotriene Antagonists on Virus-Induced Wheezing
Robert Welliver, Women and Children' Hospital, Buffalo, New York, USA |
10:15-10:45 am
|
Update on siRNA for Respiratory Viruses
John DeVincenzo, University of Tennessee, Memphis, USA |
10:45-11:15 am
|
COFFEE BREAK
Sponsored by The Macrae Group |
11:15-11:30 am
|
The Emergence of Adamantane Resistance in
Influenza A(H1) Viruses in Australia and Regionally in 2006
Ian Barr,
WHO Collaborating Centre for Influenza, Parkville, Melbourne, Australia |
11:30-11:45 am
|
In vivo Virus-inhibitory Effects of T-705 Against
Influenza A and B Virus Strains<br>
Donald F. Smee, Utah State University,
Logan, Utah, United States |
11:45-12:00 pm
|
Development of DAS181 as a Broad-spectrum
Treatment for Influenza
Fang Fang, NexBio Inc., San Diego, California,
United States |
12:00-12:15 pm
|
A Double-blind, Randomized, Placebo-controlled
Study to Evaluate the Safety and efficacy of RSV604 in Adults with
Respiratory Syncytial Virus (RSV) Infection Following Stem Cell
Transplantation
Francisco Marty, Brigham & Women’s Hospital, Dana
Farber Institute, Boston, Massachusetts, United States |
12:15-12:30 pm
|
Wrap Up and Concluding Remarks
Robert Webster & Frederick Hayden |
| 12:30-1:00 pm |
Closed Panel |
